These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25065013)

  • 41. Management of connective tissue diseases associated interstitial lung disease: a review of the published literature.
    Wallace B; Vummidi D; Khanna D
    Curr Opin Rheumatol; 2016 May; 28(3):236-45. PubMed ID: 27027811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.
    Khanna D; Berrocal VJ; Giannini EH; Seibold JR; Merkel PA; Mayes MD; Baron M; Clements PJ; Steen V; Assassi S; Schiopu E; Phillips K; Simms RW; Allanore Y; Denton CP; Distler O; Johnson SR; Matucci-Cerinic M; Pope JE; Proudman SM; Siegel J; Wong WK; Wells AU; Furst DE
    Arthritis Rheumatol; 2016 Feb; 68(2):299-311. PubMed ID: 26808827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis.
    Khanna D; Berrocal VJ; Giannini EH; Seibold JR; Merkel PA; Mayes MD; Baron M; Clements PJ; Steen V; Assassi S; Schiopu E; Phillips K; Simms RW; Allanore Y; Denton CP; Distler O; Johnson SR; Matucci-Cerinic M; Pope JE; Proudman SM; Siegel J; Wong WK; Wells AU; Furst DE
    Arthritis Care Res (Hoboken); 2016 Feb; 68(2):167-78. PubMed ID: 26806474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials.
    Khanna D; Nagaraja V; Tseng CH; Abtin F; Suh R; Kim G; Wells A; Furst DE; Clements PJ; Roth MD; Tashkin DP; Goldin J
    Arthritis Res Ther; 2015 Dec; 17():372. PubMed ID: 26704522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systemic sclerosis: commonly asked questions by rheumatologists.
    Young A; Khanna D
    J Clin Rheumatol; 2015 Apr; 21(3):149-55. PubMed ID: 25807095
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.
    Young A; Khanna D
    Curr Opin Rheumatol; 2015 May; 27(3):241-8. PubMed ID: 25775190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic sclerosis in 2014: Advances in cohort enrichment shape future of trial design.
    Allanore Y; Distler O
    Nat Rev Rheumatol; 2015 Feb; 11(2):72-4. PubMed ID: 25561368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Old medications and new targeted therapies in systemic sclerosis.
    Nagaraja V; Denton CP; Khanna D
    Rheumatology (Oxford); 2015 Nov; 54(11):1944-53. PubMed ID: 25065013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis.
    Lin AT; Clements PJ; Furst DE
    Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular complications of scleroderma.
    Guiducci S; Giacomelli R; Cerinic MM
    Autoimmun Rev; 2007 Sep; 6(8):520-3. PubMed ID: 17854742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosis.
    Kayser C; de Oliveira Delgado SM; Zimmermann AF; Horimoto AMC; Del Rio APT; de Souza Müller C; Camargo CZ; Lupo CM; de Moraes DA; Do Rosário E Souza EJ; Santos FPST; Sekiyama JY; Lonzetti LS; de Oliveira Martins LV; Bezerra MC; Bredemeier M; Oliveira MC; da Fonseca Salgado MC; Miossi R; de Araújo Fontenele SM; Hax V; Dantas AT; Sampaio-Barros PD
    Adv Rheumatol; 2024 Jul; 64(1):52. PubMed ID: 38987832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is there evidence for vasculitis in systemic sclerosis?
    Saketkoo LA; Distler O
    Curr Rheumatol Rep; 2012 Dec; 14(6):516-25. PubMed ID: 23065452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.
    van Laar JM; Farge D; Sont JK; Naraghi K; Marjanovic Z; Larghero J; Schuerwegh AJ; Marijt EW; Vonk MC; Schattenberg AV; Matucci-Cerinic M; Voskuyl AE; van de Loosdrecht AA; Daikeler T; Kötter I; Schmalzing M; Martin T; Lioure B; Weiner SM; Kreuter A; Deligny C; Durand JM; Emery P; Machold KP; Sarrot-Reynauld F; Warnatz K; Adoue DF; Constans J; Tony HP; Del Papa N; Fassas A; Himsel A; Launay D; Lo Monaco A; Philippe P; Quéré I; Rich É; Westhovens R; Griffiths B; Saccardi R; van den Hoogen FH; Fibbe WE; Socié G; Gratwohl A; Tyndall A;
    JAMA; 2014 Jun; 311(24):2490-8. PubMed ID: 25058083
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.